Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature
Identifieur interne : 005413 ( Main/Exploration ); précédent : 005412; suivant : 005414Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature
Auteurs : Singer [États-Unis] ; Anthony E. Lang [Canada] ; Oksana Suchowersky [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 1997-05.
English descriptors
- KwdEn :
- Adolescent, Adult, Adult onset, Age of Onset, Anticonvulsants (therapeutic use), Brain (blood supply), Brain (pathology), Cognition Disorders, Electroencephalography, Epilepsies, Myoclonic (diagnosis), Epilepsies, Myoclonic (drug therapy), Female, Humans, Immunoglobulin G (immunology), Magnetic Resonance Imaging, Male, Measles virus, Measles virus (immunology), Measles virus (pathogenicity), Movement Disorders, Subacute Sclerosing Panencephalitis (etiology), Subacute Sclerosing Panencephalitis (pathology), Subacute sclerosing panencephalitis, Tomography, X-Ray Computed, Vision Disorders.
- MESH :
- chemical , immunology : Immunoglobulin G.
- chemical , therapeutic use : Anticonvulsants.
- blood supply : Brain.
- diagnosis : Epilepsies, Myoclonic.
- drug therapy : Epilepsies, Myoclonic.
- etiology : Subacute Sclerosing Panencephalitis.
- immunology : Measles virus.
- pathogenicity : Measles virus.
- pathology : Brain, Subacute Sclerosing Panencephalitis.
- Adolescent, Adult, Age of Onset, Cognition Disorders, Electroencephalography, Female, Humans, Magnetic Resonance Imaging, Male, Movement Disorders, Tomography, X-Ray Computed, Vision Disorders.
Abstract
Subacute sclerosing panencephalitis (SSPE) is mainly thought of as a disorder of childhood and adolescence and may not be readily recognized when presenting later in life. Prior reports have suggested that adult‐onset SSPE may have atypical features. We have added two cases to the existing literature on adult‐onset SSPE, compared them with a more classic juvenile presentation, and extensively reviewed those reports that were published after the etiological link with the measles virus had been established. Adult‐onset SSPE patients present at a mean age of 25.4 years (range 20–35 years). They have a higher proportion of either negative history of measles exposure or undocumented history by the reporting authors. Those with available history of measles exposure tend to have it either earlier (younger than 3 years old) or later (after 9 years) than the usual childhood measles infection. Where the primary infection is known, unusually long measles‐to‐SSPE intervals have been documented, ranging from 14 to 22 years. None of the cases followed measles vaccination. Visual symptomatology was very frequent, with 8 of the 13 cases reviewed having a purely ophthalmological presentation; only 2 patients presented with behavioral changes. Although the course of the disease was progressive and fatal in the majority, there appeared to be a higher rate of spontaneous remission as compared with childhood‐onset SSPE. Myoclonus, spastic hemiparesis, bradykinesia, and rigidity were the predominant motor manifestations. Neuropathology revealed cortical and subcortical gray matter involvement preferentially of the occipital lobes, thalamus, and putamen. The importance of recognizing the spectrum of potential presentations of SSPE and providing an early diagnosis will increase as more effective treatments become available.
Url:
DOI: 10.1002/mds.870120313
Affiliations:
- Canada, États-Unis
- Alberta, Floride, Ontario
- Calgary, Toronto
- Université de Calgary, Université de Toronto
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000029
- to stream Istex, to step Curation: 000029
- to stream Istex, to step Checkpoint: 003A37
- to stream PubMed, to step Corpus: 004677
- to stream PubMed, to step Curation: 004677
- to stream PubMed, to step Checkpoint: 004721
- to stream Ncbi, to step Merge: 004D05
- to stream Ncbi, to step Curation: 004D05
- to stream Ncbi, to step Checkpoint: 004D05
- to stream Main, to step Merge: 008442
- to stream Main, to step Curation: 005413
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature</title>
<author><name sortKey="Singer" sort="Singer" uniqKey="Singer" last="Singer">Singer</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
<author><name sortKey="Suchowersky, Oksana" sort="Suchowersky, Oksana" uniqKey="Suchowersky O" first="Oksana" last="Suchowersky">Oksana Suchowersky</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:76BC0084B18E40A488FDE866389FE5ADF700575F</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120313</idno>
<idno type="url">https://api.istex.fr/document/76BC0084B18E40A488FDE866389FE5ADF700575F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000029</idno>
<idno type="wicri:Area/Istex/Curation">000029</idno>
<idno type="wicri:Area/Istex/Checkpoint">003A37</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Singer:adult:onset:subacute</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9159729</idno>
<idno type="wicri:Area/PubMed/Corpus">004677</idno>
<idno type="wicri:Area/PubMed/Curation">004677</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004721</idno>
<idno type="wicri:Area/Ncbi/Merge">004D05</idno>
<idno type="wicri:Area/Ncbi/Curation">004D05</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D05</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Singer C:adult:onset:subacute</idno>
<idno type="wicri:Area/Main/Merge">008442</idno>
<idno type="wicri:Area/Main/Curation">005413</idno>
<idno type="wicri:Area/Main/Exploration">005413</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature</title>
<author><name sortKey="Singer" sort="Singer" uniqKey="Singer" last="Singer">Singer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Clinic, Department of Neurology, University of Miami School of Medicine, Miami, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Neurology, Faculty of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Suchowersky, Oksana" sort="Suchowersky, Oksana" uniqKey="Suchowersky O" first="Oksana" last="Suchowersky">Oksana Suchowersky</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Movement Disorders Clinic, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-05">1997-05</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="342">342</biblScope>
<biblScope unit="page" to="353">353</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">76BC0084B18E40A488FDE866389FE5ADF700575F</idno>
<idno type="DOI">10.1002/mds.870120313</idno>
<idno type="ArticleID">MDS870120313</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Adult onset</term>
<term>Age of Onset</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Brain (blood supply)</term>
<term>Brain (pathology)</term>
<term>Cognition Disorders</term>
<term>Electroencephalography</term>
<term>Epilepsies, Myoclonic (diagnosis)</term>
<term>Epilepsies, Myoclonic (drug therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Immunoglobulin G (immunology)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Measles virus</term>
<term>Measles virus (immunology)</term>
<term>Measles virus (pathogenicity)</term>
<term>Movement Disorders</term>
<term>Subacute Sclerosing Panencephalitis (etiology)</term>
<term>Subacute Sclerosing Panencephalitis (pathology)</term>
<term>Subacute sclerosing panencephalitis</term>
<term>Tomography, X-Ray Computed</term>
<term>Vision Disorders</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term>
</keywords>
<keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Epilepsies, Myoclonic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Epilepsies, Myoclonic</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Subacute Sclerosing Panencephalitis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Measles virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Measles virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
<term>Subacute Sclerosing Panencephalitis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age of Onset</term>
<term>Cognition Disorders</term>
<term>Electroencephalography</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Movement Disorders</term>
<term>Tomography, X-Ray Computed</term>
<term>Vision Disorders</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Subacute sclerosing panencephalitis (SSPE) is mainly thought of as a disorder of childhood and adolescence and may not be readily recognized when presenting later in life. Prior reports have suggested that adult‐onset SSPE may have atypical features. We have added two cases to the existing literature on adult‐onset SSPE, compared them with a more classic juvenile presentation, and extensively reviewed those reports that were published after the etiological link with the measles virus had been established. Adult‐onset SSPE patients present at a mean age of 25.4 years (range 20–35 years). They have a higher proportion of either negative history of measles exposure or undocumented history by the reporting authors. Those with available history of measles exposure tend to have it either earlier (younger than 3 years old) or later (after 9 years) than the usual childhood measles infection. Where the primary infection is known, unusually long measles‐to‐SSPE intervals have been documented, ranging from 14 to 22 years. None of the cases followed measles vaccination. Visual symptomatology was very frequent, with 8 of the 13 cases reviewed having a purely ophthalmological presentation; only 2 patients presented with behavioral changes. Although the course of the disease was progressive and fatal in the majority, there appeared to be a higher rate of spontaneous remission as compared with childhood‐onset SSPE. Myoclonus, spastic hemiparesis, bradykinesia, and rigidity were the predominant motor manifestations. Neuropathology revealed cortical and subcortical gray matter involvement preferentially of the occipital lobes, thalamus, and putamen. The importance of recognizing the spectrum of potential presentations of SSPE and providing an early diagnosis will increase as more effective treatments become available.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Alberta</li>
<li>Floride</li>
<li>Ontario</li>
</region>
<settlement><li>Calgary</li>
<li>Toronto</li>
</settlement>
<orgName><li>Université de Calgary</li>
<li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Singer" sort="Singer" uniqKey="Singer" last="Singer">Singer</name>
</region>
</country>
<country name="Canada"><region name="Ontario"><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</region>
<name sortKey="Suchowersky, Oksana" sort="Suchowersky, Oksana" uniqKey="Suchowersky O" first="Oksana" last="Suchowersky">Oksana Suchowersky</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005413 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005413 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:76BC0084B18E40A488FDE866389FE5ADF700575F |texte= Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature }}
This area was generated with Dilib version V0.6.23. |